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Background: Gait disorders, a highly prevalent condition in older adults, are associated
with several adverse health consequences. Gait analysis allows qualitative and
quantitative assessments of gait that improves the understanding of mechanisms
of gait disorders and the choice of interventions. This manuscript aims (1) to
give consensus guidance for clinical and spatiotemporal gait analysis based on
the recorded footfalls in older adults aged 65 years and over, and (2) to
provide reference values for spatiotemporal gait parameters based on the recorded
footfalls in healthy older adults free of cognitive impairment and multi-morbidities.
Beauchet et al. Gait Analysis in the Elderly
Methods: International experts working in a network of two different consortiums (i.e.,
Biomathics and Canadian Gait Consortium) participated in this initiative. First, they
identified items of standardized information following the usual procedure of formulation
of consensus findings. Second, they merged databases including spatiotemporal
gait assessments with GAITRite® system and clinical information from the “Gait,
cOgnitiOn & Decline” (GOOD) initiative and the Generation 100 (Gen 100) study. Only
healthy—free of cognitive impairment and multi-morbidities (i.e., ≤ 3 therapeutics taken
daily)—participants aged 65 and older were selected. Age, sex, body mass index, mean
values, and coefficients of variation (CoV) of gait parameters were used for the analyses.
Results: Standardized systematic assessment of three categories of items, which
were demographics and clinical information, and gait characteristics (clinical and
spatiotemporal gait analysis based on the recorded footfalls), were selected for the
proposed guidelines. Two complementary sets of items were distinguished: a minimal
data set and a full data set. In addition, a total of 954 participants (mean age 72.8 ± 4.8
years, 45.8% women) were recruited to establish the reference values. Performance of
spatiotemporal gait parameters based on the recorded footfalls declined with increasing
age (mean values and CoV) and demonstrated sex differences (mean values).
Conclusions: Based on an international multicenter collaboration, we propose
consensus guidelines for gait assessment and spatiotemporal gait analysis based on
the recorded footfalls, and reference values for healthy older adults.
Keywords: gait, aged, guidelines, reference values
INTRODUCTION
Gait—the medical term used to describe the human locomotor
movement of walking in healthy adults—is simple in terms of
execution, but complex in terms of biomechanics and motor
control (Nutt et al., 1993; Zajac et al., 2002; McCann and
Higginson, 2008; Dicharry, 2010; Kuo and Donelan, 2010). Gait
is usually considered as a dynamic balance condition in which
the body’s center of gravity is maintained within a slight base
of support while moving (Farley and Ferris, 1998; Dicharry,
2010; Kuo and Donelan, 2010). During the past decade, it
has been highlighted that even the simplest walking condition,
such as straight-line walking at a comfortable steady-state pace
without any disturbance, involves important cortical networks
and cognitive functions (Alexander and Crutcher, 1990; Seidler
et al., 2010; Zwergal et al., 2012; Beauchet et al., 2015b, 2016).
Numerous studies show that gait changes over an individual’s
lifetime (Nutt et al., 1993; Hausdorff et al., 1996; Nutt, 2001;
Verghese et al., 2006; Montero-Odasso et al., 2012). Although,
gait disorders are common in older (i.e., >65 years) adults,
they are not unavoidable. With aging, there are physiological
changes in the sensorimotor systems, which when combined
with adverse effects of chronic diseases, may cause gait disorders
(i.e., a deviation of normal gait performance leading to gait
instability and related adverse health consequences; American
Geriatrics Society and British Geriatrics Society and American
Academy of Orthopedic Surgeons Panel on Falls Prevention,
2001; Nutt, 2001). Gait disorders in old age are a risk factor for
falls and are associated with increased morbidity, mortality, loss
of independent living, disability, altered quality of life, and as
such can lead to increased health care expenditures (Panel on
Prevention of Falls in Older Persons and American Geriatrics
Society and British Geriatrics Society, 2011). The prevalence
of gait disorders can be as high as 80% in the oldest-old
(i.e., >85 years) age category and gait disorders represent a
major worldwide concern based on their expanding prevalence
(American Geriatrics Society and British Geriatrics Society and
American Academy of Orthopedic Surgeons Panel on Falls
Prevention, 2001; Verghese et al., 2006; Panel on Prevention
of Falls in Older Persons and American Geriatrics Society and
British Geriatrics Society, 2011).
The assessment of gait characteristics in older adults has
enhanced our understanding of themechanisms of gait disorders,
which have been helpful in developing preventive and curative
interventions (Nutt, 2001; Panel on Prevention of Falls in Older
Persons and American Geriatrics Society and British Geriatrics
Society, 2011). Clinical gait assessment has typically been based
on visual observation (Nutt, 2001). However, this approach has
two main limitations. First, visual observation depends on the
background and experience of the clinician who performs the
gait assessment, which explains the poor inter-rater reliability of
this approach (Eastlack et al., 1991; Kressig et al., 2006). Second,
a limited amount of information is collected, which limits the
possibility of detecting gait impairments at an early stage as well
as understanding the disorganization of gait control (Kressig
et al., 2006; Montero-Odasso et al., 2012). The use of quantitative
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and standardized clinical tests, such as the Timed Up & Go
(TUG) test has been shown to be useful as a complement to
visual gait observation (Podsiadlo and Richardson, 1991). Indeed,
it improves the inter-rater reliability of gait assessment and
provides a common objective language that facilitates exchanges
between clinicians and researchers. However, it is insufficient
in detecting relevant subtle gait abnormalities like changes in
gait variability (Kressig et al., 2006; Beauchet et al., 2014a). For
instance, an increase in stride time variability (STV) has been
identified as the best motor phenotype of cognitive decline in
older adults, suggesting that increases in STV could be used to
improve the prediction of dementia such as Alzheimer Disease
(AD; Montero-Odasso et al., 2012; Beauchet et al., 2014a). It has
been proposed that subclinical gait changes may be used as a
surrogate marker of development of future diseases or adverse
clinical outcomes, such as falls or disability (Verghese et al., 2009;
Rao et al., 2011; Ayers et al., 2014; Beauchet et al., 2014a; Artaud
et al., 2015).
Currently, advanced technology has changed the practice of
gait analysis because it surpasses the limits of clinical observation
(i.e., visual observation and standardized test) of gait and is
easily accessible and feasible (Webster et al., 2005; Beauchet
et al., 2008). The initial trade-off between the accuracy of gait
measuring systems and their clinical use due to cost, labor-
intensity, and time consumption has disappeared. There are
numerous validated and user-friendly portable gait analysis
systems, like electronic gait mats, insole footswitch systems
and body worn inertial sensor systems that allow objective gait
parameters to be easily obtained at low cost (Kressig et al., 2006;
Beauchet et al., 2008). Gait analysis systems may be separated
into three categories: the first includes non-wearable sensors and
consists of devices based on image processing and pressure-
sensitive floor sensors, such as the GAITRite R© system, which
provided all spatiotemporal parameters based on the recorded
footfalls. The second category includes wearable sensors such as
pressure-sensitive insoles and body worn accelerometers/inertial
measurement units (IMUs), with this last category providing
the opportunity to analyse gait outside the laboratory and
obtain information about gait during the individual’s everyday
activities. The third category of devices includes a combination
of both previous systems. Though promising, the research on
gait characteristics derived from wearable sensors in free living
situations is still in its infancy. It is therefore too early to give
strong recommendations on gait assessment and on the protocols
that should be used to derive reliable and valid information about
gait from these systems.
While this is an important advancement for researchers, as
well as for patients and clinicians, it presents a new challenge
based on a combination of different issues: (1) the lack of
consensus on which gait parameters to assess and their clinical
relevance; (2) the lack of a consensus concerning data acquisition;
(3) the lack of standardized data from a large number of people
to correctly define reference values related to healthy aging;
(4) the excessive fragmentation, dispersion and confinement
of data, skills, and knowledge of teams of researchers and/or
clinicians; (5) and finally the lack of sufficient research funding
in science and medicine. The successful future of scientific and
medical research in the field of gait disorders mainly depends
on sharing and/or pooling of resources, research and databases
between teams. Hence, there is an emergence of networks with
a common interest to provide mutual assistance and useful
information. Recently, two networks have been formalized, with
the aim of helping clinicians and researchers to increase their
knowledge and improve the field of age-related gait disorders by
sharing knowledge and data sets: these are (1) the Biomathics
(Beauchet et al., 2014c) and (2) the Canadian Gait Consortium.
Both consortiums connect academic research teams working
on age-related gait changes, and share their databases in order
to compound a larger, more comprehensive and representative
database. This provides fast and comprehensive answers to
research questions with minimal additional financial resources
and large population-based samples. Furthermore, it is likely that
some objectives identified in a specific study may be relevant
to other teams, and at the very least the initial investigators
can respond to queries of a secondary team. In such cases, the
requesting team launches an initiative within the consortium and
contacts all team members who may be able to help. Willing
researchers are included in the initiative to participate in the
research, contribute to the collaborative publication and be
included in the list of co-authors depending on their contribution
to the study and the number of included participants. For
instance, the Biomathics consortium recently focused on gait
disorders in older individuals with cognitive decline: the objective
was to compare spatiotemporal gait parameters based on the
recorded footfalls in cognitively healthy individuals (CHIs),
individuals with amnestic (aMCI) and non-amnestic mild
cognitive impairment (naMCI), and individuals with mild and
moderate stages AD and non-Alzheimer’s disease (non-AD;
Allali et al., 2016). They merged databases for a first initiative
called “Gait, cOgnitiOn & Decline” (GOOD), which involved
2717 participants and represented the largest database in this field
of research. The GOOD study demonstrated that spatiotemporal
gait parameters are more disturbed in the advanced stages of
dementia with worse performance in the non-AD dementias than
in AD. These results suggest that quantitative gait parameters
may be used for improving the accuracy of classifying dementia
(Allali et al., 2016), as well as supporting clinical follow-ups that
try to prevent adverse events such as falls or disability.
This first initiative underscored the requirement of utilizing
standardized assessment when performing spatiotemporal gait
analysis. Although, some reference values for gait parameters
in older adults already exist (Oberg et al., 1993; Oh-Park et al.,
2010; Bohannon and Williams Andrews, 2011; Hollman et al.,
2011; Hass et al., 2012), this first initiative demonstrated that
there is a need for quantitative reference values of spatiotemporal
gait parameters for large numbers of healthy older adults.
Importantly, older adults are considered to be healthy when
they are free of cognitive deficits and comorbidities. Combining
and integrating evaluations performed in populations from
different countries is crucial for the development of future
research on gait disorders. Indeed, the definition of gait disorders
requires comparisons with quantitative reference values for
spatiotemporal gait parameters in healthy older adults with
diverse social, cultural, ethnic, and demographic backgrounds.
Based on this first experience of the GOOD initiative, the
Biomathics and Canadian Gait Consortiums decided to launch
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an initiative with the following aims: (1) to give consensus
guidance for clinical and spatiotemporal gait analysis based
on the recorded footfalls in older adults aged 65 years and
over, and (2) to provide reference values for spatiotemporal
gait parameters based on the recorded footfalls in healthy older
(i.e., >65 years) adults free of cognitive impairment and multi-
morbidities.
METHODS
Guidelines for Clinical and Spatiotemporal
Gait Analysis Based on the Recorded
Footfalls in Older Adults Aged 65 Years and
Over
The guidelines for clinical and spatiotemporal gait analysis based
on the recorded footfalls in older adults followed the usual
procedure of formulation of a consensus finding, consisting of
a three-step process (Annweiler et al., 2015). In the first step,
between May and October 2015, the lead author (OB) invited
members of the Biomathics and Canadian Gait Consortiums
composed with experts of gait disorders in aging, to form a
group. The members of both consortiums are experts in gait
and/or movement and are presented in Table 1. In a second step
from July 2015 to May 2016, all experts communicated by email,
phone calls or videoconferencing with the first author to identify
items required for spatiotemporal gait analysis in older adults.
The first author, as the leader of both consortiums, contacted
each member to explain the initiative, obtain their agreement to
the consensus procedures, and propose an initial version of the
guidelines. Each member of the consortium formulated changes
and/or proposed additional information. The first author merged
all changes and wrote the second version of the guidelines.
All experts reviewed this version and finally a consensual
TABLE 1 | Composition of Biomathics and Canadian Gait Consortiums.
Country/Canadian
province
Town University Centre Reference person
BIOMATHICS CONSORTIUM
Australia Hobart University of Tasmania Menzies Institute of Medical Research Michele L Callisaya; PhD
Melbourne University of Melbourne
& Western Health
Australian Institute for Musculoskeletal
Science
Gustavo Duque; MD, PhD
Victoria Monash University Department of Medicine Velandai Srikanth; PhD
Belgium Antwerp University of Antwerp Department of geriatrics and department of
primary and interdisciplinary care (ELIZA)
Anne-Marie De Cock; MD
Liege University of Liege Department of Geriatrics Sylvie Gilain; MD
France Angers University of Angers Department of Neuroscience, Geriatrics
division
Cyrille P Launay; MD, PhD
Japan Chiba-ken University of Health and Welfare Department of Physical Therapy, School of
Health Sciences at Narita International
Ryuichi Sawa; PhD
Luxembourg Luxembourg-city Zitha Senior Centre for Memory and Mobility Jean-Paul Steinmetz; PhD
Norway Trondheim Norwegian University of Science
and Technology
Department of Neuromedicine and
Movement Science
Jorunn L. Helbostad; PT,
PhD
USA New York Yeshiva University Department of Neurology, Division of
Cognitive & Motor Aging
Joe Verghese; MD, MBBS
Switzerland Basel University of Basel Basel University Center for Medicine of Aging Reto W. Kressig; MD
Geneva University of Geneva Department of Neurology Gilles Allali; MD, PhD
CANADIAN GAIT CONSORTIUM
Alberta Edmonton University of Alberta Department of Medicine, Division of
Neurology
Richard Camicioli; MD, PhD
British Columbia Vancouver University of British Columbia Aging, Mobility, and Cognitive Neuroscience
Lab Djavad Mowafaghian Centre for Brain
Health
Teresa Liu-Ambrose; PT,
PhD
Manitoba Winnipeg University of Manitoba College of Rehabilitation Sciences Tony Szturm; PT, PhD
Quebec Montreal University of Concordia Perform institute Louis Bherer; PhD
University of McGill Department of Medicine, Division of
Geriatrics, Jewish General Hospital
Olivier Beauchet; MD, PhD
University of Montreal Institut universitaire de gériatrie
Montreal Heart Institute Research Center and
Departement of Medicine
Sébastien Grenier; PhD
Louis Bherer; PhD
Sherbrooke University of Sherbrooke Research Centre on Aging Léonard Guillaume; PhD
New Brunswick Fredericton University of New Brunswick Richard J. Currie Center Victoria L. Chester; PhD
Saskatchewan Regina University of Regina Neuromechanical Research Centre, Faculty
of Kinesiology and Health Studies
John M. Barden; PhD
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agreement was obtained. A dataset of common items divided
into three categories was selected: demographic characteristics,
clinical characteristics, and gait characteristics. Furthermore, a
standardized procedure for spatiotemporal gait analysis based
on the recorded footfalls was defined and two types of datasets
were individualized: a minimum dataset corresponding to items
required for all gait analysis in older individuals, and a full dataset
corresponding to items of the minimum dataset plus additional
items recorded when possible and for specific purposes. All
selected items are shown in Table 2.
Quantitative Reference Values for
Spatiotemporal Gait Parameters Based on
the Recorded Footfalls
Participant Selection
Data were extracted from two databases: the GOOD initiative
(Clinical trials registration number: NCT02350270) (Allali et al.,
2016) and the Generation 100 (Clinical trials registration
number: NCT01666340) (Stensvold et al., 2015). The GOOD
initiative was based on a cross-sectional design such that
the main objective was to compare spatiotemporal gait
characteristics based on the recorded footfalls of CHIs, and
participants with MCI or dementia. Data collection, study
procedures and criteria for categorization of participants
have been described in detail elsewhere (Allali et al., 2016).
In brief, data from seven countries (Australia, Belgium,
France, India, Luxembourg, Switzerland, and the United
States) were merged. Data sources were the “Tasmanian
Study of Cognition and Gait” (TASCOG) (Tasmanian), the
Mechelen memory clinic database (Belgium), the “Gait and
Alzheimer Interactions Tracking” (GAIT) study (France),
the “Kerala-Einstein Study” (KES) (India), the Center for
Memory and Mobility (Luxembourg), the “Central Control
of Mobility in Aging” (US), and the Basel mobility center
(Switzerland).
The Generation 100 study is a population-based large
randomized controlled clinical trial (Stensvold et al., 2015). The
primary aim of this study is to examine the effects of 5 years
of exercise training on mortality in the elderly (Stensvold et al.,
2015). The data collection and study procedures have been
described in detail elsewhere (Stensvold et al., 2015). In summary,
it is an ongoing phase IIb clinical trial. The participants are
stratified by sex and marital status and randomized 1:1 into an
exercise training group or a control group. They are assessed at
baseline and at follow-up after 1, 3, and 5 years. For this analysis,
we used the data collected at baseline.
Exclusion criteria for the present study were age <65 years,
non-Caucasian, cognitive decline (i.e., MCI and dementia),
walking with personal assistance, polypharmacy defined as more
than 3 therapeutic drug classes taken daily, history of falls in the
past 12-month period, the presence of depressive and/or anxiety
symptoms, moderate or severe distance vision impairment (when
information was accessible), and absence of spatiotemporal gait
data. From the 2,717 participants initially recruited in the
GOOD initiative, 548 (20.2%) healthy older adults met the
inclusion criteria. A total of 457 (29.7%) participants from the
1,541 participants who had a gait assessment at baseline in the
Generation 100 study met the inclusion criteria. Fifty-one of the
1005 (19.7%) identified participants were excluded because of
incomplete gait data. Finally, 954 participants were included in
the analysis.
Assessment
Age, sex, and anthropometric measures (i.e., height in metres
and weight in kilograms) were recorded. Body mass index (BMI,
in kg/m2) was also calculated. Spatiotemporal gait parameters
based on the recorded footfalls were measured during steady-
state walking using the GAITRite R©-system. This gait system
is an electronic walkway with an integrated pressure-sensitive
electronic surface connected to a portable computer via an
interface cable. The GAITRite R©-system is a well-established
method of quantifying gait and provides reliable and accurate
measures of spatiotemporal gait parameters. Spatiotemporal gait
parameters have shown excellent test-retest reliability in clinical
and research settings in community-dwelling older people when
using the GAITRite R©-system (Brach et al., 2008). During the
past decade over 100 manuscripts have been published using data
collected and processed with the GAITRite R© system.
The active recording area of the gait mats ranged from 4.6m
(TASCOG study) to 7.9m (GAIT study). Participants completed
one (GAIT, CCMA, and KES studies; the Mechelen memory
clinic, the Centre for Memory and Mobility of Luxembourg-city,
The Basel mobility center), two (Generation 100 study) or six
(TASCOG study) trials at their usual self-selected walking speed
in a quiet, well-lit environment, wearing their own footwear. The
mean of the 2 (the Generation 100) or 6 trials (the TASCOG
studies) was used to calculate the gait variables. The mean value
and coefficient of variation [CoV = (standard deviation/mean)
× 100] of the spatiotemporal gait parameters were used as
outcomes. For a list of the included spatiotemporal variables, see
Table 2.
Standard Protocol Approvals and Registrations
Each site involved in this study obtained approval from their
local ethics committee to conduct site-specific assessments:
the Southern Tasmanian Health and Medical Human Research
Ethics Committee for the TASCOG study (Australia), the
ethics committee of Angers University hospital for the GAIT
study (France), the ethics committee of Emmaus—St Maarten
General Hospital Mechelen for the Mechelen memory clinic
database (Belgium), the institutional ethics committee of
Baby Memorial Hospital for KES study (India), the ethics
committee of Luxembourg for the Center for Memory and
Mobility database (Luxembourg), the ethics committee
of Albert Einstein College of Medicine for the “Central
Control of Mobility in Aging” (US) study, and the ethics
committee of Basel for the Basel mobility center database
(Switzerland). The ethics committee of Angers (France)
University hospital approved the GOOD initiative (2014/17).
The regional committee of Mid Norway for Medical and Health
Research Ethics approved the transfer and the merging (number
2015/1797) of the Generation 100 database with the GOOD
database.
Frontiers in Human Neuroscience | www.frontiersin.org 5 August 2017 | Volume 11 | Article 353
Beauchet et al. Gait Analysis in the Elderly
TABLE 2 | Selected items for gait analysis in the elderly.
Items for the minimum dataset Additional items for the full dataset
DEMOGRAPHIC CHARACTERISTICS
Age (year)
Sex
Ethnicity coded as follows: 1, Black; 2, Caucasian; 3, Asian; 4, Other
CLINICAL CHARACTERISTICS
Height (m)
Weight (kg)
Medication; Number of therapeutic classes used per day >3 (coded yes vs. no)
Number of therapeutic classes taken daily
Use of psychoactive drugs (i.e., benzodiazepines, antidepressants, neuroleptics)
(coded yes vs. no)
History of falls (i.e., defined as an event resulting in a person coming to rest
unintentionally on the ground or at another lower level, not as the result of a major
intrinsic event or an overwhelming hazard) in the previous 12-month period (coded
yes vs. no)
Recurrent falls (i.e., >2) (coded yes vs. no)
Severe falls (i.e., fractures, cranial trauma, large and/or deep skin lesions, post-fall
syndrome; inability to get up; time on ground >1 h; hospitalization) (coded yes vs.
no).
Fear of falling (Are you afraid of falling? Never, almost never, sometimes, often, and
very often)
Neurological diseases:
• Dementia (coded yes vs. no) • Cognitive complaint (coded yes vs. no)
• Mild cognitive impairment (coded yes vs. no)
• Dementia (coded yes vs. no), if yes stage (i.e., mild, moderate, severe) and
etiology (i.e., AD, non-AD neurodegenerative, non-AD vascular, mixed)
• Global cognitive performance: MoCA score (Nasreddine et al., 2005)
• Other (coded yes vs. no) • Parkinson’s disease or parkinsonian syndromes (coded yes vs. no)
• Idiopathic normal pressure hydrocephalus (coded yes vs. no)
• Cerebellar disease (coded yes vs. no)
• Myelopathy (coded yes vs. no)
• Peripheral neuropathy (coded yes vs. no)
Depressive symptoms (coded yes vs. no) 4-item Geriatric Depression Scale score (Shah et al., 1997)
Anxiety symptoms (coded yes vs. no) 5-item Geriatric Anxiety Inventory (Byrne and Pachana, 2011)
Major orthopedic diagnoses (e.g., osteoarthritis) involving the lumbar vertebrae,
pelvis or lower extremities (coded yes vs. no)
Vision disorders (coded yes vs. no) Distance binocular vision measured at 5m with a standard scale, vision assessed
with corrective lenses if needed
Lower limb proprioception disorders (coded yes vs. no) Lower limb proprioception evaluated with a graduated tuning fork placed on the
tibial tuberosity: The mean value obtained for the left and right sides (/8)
Muscle strength impairment (coded yes vs. no) Hand grip strength: mean value of the highest value of maximal isometric voluntary
contractions (3 trials) measured with computerized dynamometers expressed in
Newtons per square meter
Use of walking aid (coded yes vs. no)
GAIT CHARACTERISTICS
Clinical analysis
Subjective self-reported difficulties (coded never, almost never, sometimes, often,
and very often)
Clinical gait abnormalities (coded yes vs. no)
Timed Up & Go score (s) (Podsiadlo and Richardson, 1991) Timed Up & Go imagined form score (s) (Beauchet et al., 2010)
Walking speed: time to walk 4m at steady-state walking
(Continued)
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TABLE 2 | Continued
Items for the minimum dataset Additional items for the full dataset
Spatiotemporal analysis
• Conditions
X In a quiet, well-lit environment
X Steady state walking (acceleration and deceleration phase of 1m each)
X Wearing participant’s own footwear
X Usual self-selected walking speed
• Fast walking speed
• Dual tasking:
X Backward counting by ones from 50
X Verbal fluency task (animal names)
• Parameters
X Walking speed [mean value (cm/s)]
X Stride time [mean value (ms) and coefficient of variation (%)]
X Swing time [mean value (ms) and coefficient of variation (%)]
X Stride width [mean value (cm) and coefficient of variation (%)]
• Stride length [mean value (cm) and coefficient of variation (%)]
• Stance time [mean value (ms) and coefficient of variation (%)]
• Single support time [mean value (ms) and coefficient of variation (%)]
• Double support time [mean value (ms) and coefficient of variation (%)]
• Stride velocity [mean value (cm/s) and coefficient of variation (%)]
m, meter; kg, kilogram; s, second; cm, centimeter.
Statistics
Participants’ baseline characteristics were summarized using
means and standard deviations or frequencies and percentages.
Participants were separated into three age groups (65–74 years,
75–84 years, and >85 years), and each group was dichotomized
by sex. First, between-group comparisons were performed
using unpaired t-test or Mann–Whitney tests, as appropriate.
P < 0.0006 were considered as statistically significant after
adjustments for multiple comparisons (n = 79). Second,
multiple linear regressions showing the association of each
spatiotemporal gait parameter (dependent variable) with age and
sex (independent variable), adjusted for BMI and test center were
performed. P < 0.05 were considered as statistically significant.
All statistics were performed using SPSS (version 15.0; SPSS, Inc.,
Chicago, IL).
RESULTS
Guidelines for Clinical and Spatiotemporal
Gait Analysis Based on the Recorded
Footfalls
Two complementary sets of standardized information were
identified: a minimal data set and a full data set. All items of both
sets are shown in Table 2. They have been separated into three
categories: demographic, clinical, and gait characteristics. This
last category has been divided into clinical and spatiotemporal
gait analysis based on the recorded footfalls.
Demographic and Clinical Characteristics
Demographic (i.e., age in years, sex and ethnicity) and
anthropometric items [height in meters (m), weight in kilograms
(kg), body mass index (BMI) in kg/m2], are required because
each may influence spatiotemporal gait parameters (American
Geriatrics Society and British Geriatrics Society and American
Academy of Orthopedic Surgeons Panel on Falls Prevention,
2001; Kressig et al., 2006; Verghese et al., 2006; Beauchet et al.,
2008; Dicharry, 2010; Panel on Prevention of Falls in Older
Persons and American Geriatrics Society and British Geriatrics
Society, 2011). Given that the burden of disease can influence
gait performance, it was decided to record this information as
well (American Geriatrics Society and British Geriatrics Society
and American Academy of Orthopedic Surgeons Panel on
Falls Prevention, 2001; Panel on Prevention of Falls in Older
Persons and American Geriatrics Society and British Geriatrics
Society, 2011). Different scales have been developed to score the
burden of morbidity, but they remain difficult to use in older
adults, especially because of possible recall bias when reporting
chronic disease among individuals with cognitive disorders, and
lack of feasibility in clinical practice (due to their complexity
and value for physicians, physiotherapists, or other health care
professionals; Linn et al., 1968; Parmelee et al., 1995; Salvi
et al., 2008; de Decker et al., 2013). Recently, an independent
association was found between the Cumulative Illness Rating
Scale Geriatric form (CIRS-G), which provides a morbidity score,
and the number of drug classes taken daily (de Decker et al.,
2013). The results showed that an increase of three drug classes
corresponds to a one-point increase on the CIRS-G (de Decker
et al., 2013). This result is consistent with previous studies in the
general population, which reported that pharmacy data using
the Anatomical Therapeutic Chemical Classification (ATCC)
system might be used to provide reliable prevalence estimates
of several common comorbid conditions (Von Korff et al., 1992;
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Maio et al., 2005; Chini et al., 2011). In addition, it has been
demonstrated that pharmacy data provide a stable measure of
morbidity status, and are associated with physician-rated disease
severity as well as with individual-rated health status (Von Korff
et al., 1992). Hence, the decision was made to record the use
of drugs in the clinical assessment. Polypharmacy is defined as
the use of more than three drugs per day, which was used as
the item for the minimum data set, and was combined with the
exact number of therapeutic drug classes taken daily and the
use of psychoactive drugs (i.e., benzodiazepines, antidepressants,
neuroleptics), which was coded as yes or no in the full dataset.
Information about falls, with a fall being defined as an
event resulting in a person coming to rest unintentionally
on the ground or at another lower level, not as the result
of a major intrinsic event or an overwhelming hazard, in
the previous 12 month-period before the assessment, is also
proposed (American Geriatrics Society and British Geriatrics
Society and American Academy of Orthopedic Surgeons Panel
on Falls Prevention, 2001; Panel on Prevention of Falls in
Older Persons and American Geriatrics Society and British
Geriatrics Society, 2011). For the minimum data set, only the
existence (or not) of a fall(s) history is required, while for
the full data set information on recurrence (i.e., >2 falls)
and severity (defined as fractures, cranial trauma, large, and/or
deep skin lesions, post-fall syndrome including an association
of fear of falling (FOF), postural instability with absence of
postural reflexes, inability to get up, time on ground >1 h, and
hospitalization) are proposed for the data collection. Recently,
a systematic review and meta-analysis reported that FOF might
increase gait instability (Ayoubi et al., 2015). Thus, it was
determined to measure FOF using the single question: “Are
you afraid of falling?” with a graded answer (i.e., never,
almost never, sometimes, often, and very often) for the full
dataset.
In addition to FOF, collecting information on disorders
or diseases that directly influence gait performance is also
advised. First, information on neurological diseases (limited
to the existence or non-existence of dementia) and other
diseases (coded as yes or no) are collected for the minimal
data set. Information on memory complaints, MCI, nature
of dementia (i.e., AD, non-AD neurodegenerative, non-
AD vascular, mixed), Parkinson disease, idiopathic normal
pressure hydrocephalus, cerebellar disease, stroke, myelopathy,
and peripheral neuropathy are also proposed for the full
dataset (Alexander and Crutcher, 1990; Nutt et al., 1993;
Nutt, 2001; Verghese et al., 2006; Montero-Odasso et al.,
2012). A quantification of global cognitive functioning is also
recommended, using for example the Montreal Cognitive
Assessment (MoCA) (Nasreddine et al., 2005). In addition,
among the neuropsychiatric disorders, it is important to collect
information about depression symptoms because they can
lead to gait instability and falls. This is limited to a simple
binary question in the minimum data set and the score for
the 4-item geriatric depression scale in the full data set (Shah
et al., 1997). A measure of anxiety is also proposed using
the 5-item Geriatric Anxiety Inventory (Byrne and Pachana,
2011).
Information on major orthopedic diagnoses (e.g.,
osteoarthritis) involving the lumbar vertebrae, pelvis, or
lower extremities, coded yes vs. no, as well as the use of a walking
aid, should also be recorded (American Geriatrics Society and
British Geriatrics Society and American Academy of Orthopedic
Surgeons Panel on Falls Prevention, 2001; Panel on Prevention
of Falls in Older Persons and American Geriatrics Society and
British Geriatrics Society, 2011).
Information on sensory and motor subsystems such as muscle
strength, lower-limb proprioception and vision are required
because the age-related impairment in the performance of
these subsystems may affect gait performance (Beauchet et al.,
2014a). For the minimal data set, impairments were coded as
binary (i.e., yes or no), while in the full dataset standardized
measures are required. First, the Maximum isometric Voluntary
Contraction (MVC) of handgrip strength must be measured
with a computerized hydraulic dynamometer. The test should
be performed three times with the dominant hand. The mean
value of MVC over the three trials should be used as the
outcome measure. Second, distance binocular vision should be
measured at a distance of 5m with a standard scale (Lord et al.,
1994). Vision needs to be assessed with corrective lenses, if
used regularly. Third, lower extremity vibration sense should be
measured, using a graded tuning fork placed on a bony area,
such as the tibial tuberosity, medial malleolus or big toe. This
is correlated with proprioception, which is critical to balance
(Beauchet et al., 2014a).
Gait Characteristics
Before conducting a spatiotemporal gait analysis based on the
recorded footfalls, a standardized clinical evaluation is advised.
First, the individual’s subjective perception of gait difficulties is
registered using a single question: “Do you have any difficulty
walking?” with a graduated answer (i.e., never, almost never,
sometimes, often, and very often). Second, a visual observation
of gait during habitual walking is proposed with a binary answer
(yes vs. no) to the question “are there gait abnormalities during
physical examination?”
Third, the TUG test score and gait speed (distance divided by
ambulation time) when walking a distance of 4m at a steady-state
pace is suggested (Podsiadlo and Richardson, 1991; Goldberg and
Schepens, 2011). These measures are proposed for the minimal
dataset, while for the full data set an additional measure is
proposed; that being the time to achieve the imagined TUG
(iTUG) (Beauchet et al., 2015a). Exploring the higher levels of
gait control may be more difficult in clinical practice. There are
two alternatives: using a dual-task paradigm (i.e., walking while
simultaneously executing an attention-demanding task), or using
motor imagery of gait (i.e., the mental simulation of gait without
its actual execution; Beauchet et al., 2015a). Recently, interest
in the latter alternative has been underscored using the mental
chronometry approach applied to the TUG, a well-known motor
test used in clinical practice (Beauchet et al., 2010, 2014b, 2015a).
The TUG is a standardized assessment of a basic functional
mobility task of relevance to daily living and records the time
needed to stand up, to walk 3 m, to turn back and sit down
(Podsiadlo and Richardson, 1991). It has been reported that
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cognitive performance, and in particular executive functioning,
contributes to the temporal correspondence between executing
and imaging gait in individuals with neuropsychiatric conditions
like dementia, schizophrenia or multiple sclerosis (Linn et al.,
1968; Von Korff et al., 1992; Oberg et al., 1993; Lord et al.,
1994; Parmelee et al., 1995; Shah et al., 1997; Maio et al., 2005;
Nasreddine et al., 2005; Brach et al., 2008; Salvi et al., 2008;
Beauchet et al., 2010, 2014a,b, 2015a; Bohannon and Williams
Andrews, 2011; Byrne and Pachana, 2011; Chini et al., 2011;
Goldberg and Schepens, 2011; Allali et al., 2012; Hass et al.,
2012; Lallart et al., 2012; de Decker et al., 2013; Annweiler et al.,
2015; Ayoubi et al., 2015; Stensvold et al., 2015). It has also
been shown that older individuals with cognitive impairment
executed the iTUG more rapidly than they performed it (Allali
et al., 2012; Beauchet et al., 2015a). On the contrary, there has
been no significant difference between the two conditions in
healthy younger adults (Lallart et al., 2012). This difference in
terms of performance between pTUG and iTUG, called “delta
TUG,” can be interpreted as the awareness of movement and
physical performance, and thus may be used as a biomarker of
the disorders of higher levels of gait control (Beauchet et al., 2010,
2014b, 2015a; Allali et al., 2012; Lallart et al., 2012).
It is necessary to underscore that the spatiotemporal gait
analysis based on the recorded footfalls should be performed
in a reproducible, quiet, well-lit environment, with patients
wearing their own footwear (walking shoes, no slippers) with heel
height not exceeding 3 cm and comfortable and non-restrictive
clothing. Depending on the participant’s fall risk, the use of safety
support systems is recommended, such as a safety belt around the
participant’s waist. We recommend assessing the normal walking
condition for the minimal data set, and for the full dataset
we recommend three additional walking conditions; a fast walk
at a maximum speed, and two dual-task conditions, in which
the patient is instructed to walk normally while (a) counting
backwards by ones starting from 50 and (b) to enumerate animal
names (Kressig et al., 2006; Beauchet et al., 2012; Montero-
Odasso et al., 2012). For the dual task condition, no prioritization
should be given to a single task and the trial should be performed
to the best of the participant’s ability. Steady-state gait and gait
trials in the same walking direction are required for all conditions
and may be achieved by instructing participants to start walking
at least 1m prior to the data recording zone and stopping at
least 1m beyond it. It is also advisable to use simple, clear and
standardized walking instructions to explain the various tasks to
the participants.
Regardless of the type of category of devices used to assess gait,
we recommend using a validated system that provides reliable
measures. For the minimum data set, four gait parameters
during normal walking including the mean value of walking
speed, and mean values and coefficient of variation of stride
time, swing time and stride width need to be reported. We
suggest adding more stressful walking conditions (i.e., fast speed
and dual tasking conditions) and reporting mean values and
coefficients of variation of stride length, stance time, single and
double support, and stride velocity for the full dataset. This
choice is based on the fact that in terms of control of gait,
gait variability has been identified as a biomarker for cortical
control of gait in normal aging individuals and in individuals
with dementia (Beauchet et al., 2010, 2012, 2014b, 2015a; Allali
et al., 2012; Lallart et al., 2012). In addition, higher (i.e., worse)
STV during normal walking has been associated with lower
cognitive performance in non-demented older community-
dwellers (Beauchet et al., 2012). This result has been confirmed
by a meta-analysis underscoring that higher STV during normal
walking was related to both MCI and dementia (Beauchet et al.,
2014a). In terms of gait variability, a certain level of “healthy”
variability of the motor control system is necessary to adapt to
unexpected instability. Indeed, both high and low gait variability
during habitual walking have been reported in younger and older
CHIs with safe gait, depending on the type of gait parameters
being examined (Beauchet et al., 2009). In particular, safe gait
has been characterized by a low STV, an intermediate swing time
variability and a high stride width variability in CHIs (Beauchet
et al., 2009). These results can be explained by the fact that
temporal and spatial gait parameters appear to reflect different
constructs of gait control (Gabell and Nayak, 1984; Newell and
Corcos, 1993; Nutt et al., 1993; Nutt, 2001; Launay et al., 2013).
Stride time and stride width variability provide an indication
of control of the rhythmic stepping mechanism and dynamic
postural control, respectively, while swing time is indicative of
bothmechanisms (Gabell andNayak, 1984; Beauchet et al., 2009).
Furthermore, it is important to consider the number of steps
recorded. Indeed, the accuracy of gait variability measures are
highly dependent on obtaining a sufficient number of steps, with
a study suggesting that a minimum of 400 steps are needed to
obtain valid measures of gait variability during treadmill walking
(Faude et al., 2012). However, even if it is recommended to
have the highest number of gait cycles possible from a practical
standpoint to assess gait variability of spatiotemporal parameters,
it has been suggested that a minimum of three consecutive gait
cycles should be obtained for both the left and right sides (i.e.,
a total of six gait cycles; Kressig et al., 2006). Furthermore,
including steps from several shorter walks is recommended when
obtaining the number of steps over a long walking distance is not
possible.
For the collection of gait data, we suggest that gait should
be assessed without assistive devices whenever possible. When
a device is required it is important to describe the type of
device used by the individual. Given that there are no established
reference values for assistive devices, the first assessment should
be used as the reference point for individuals who repeatedly use
the same device.
The operational definitions of spatiotemporal gait parameters,
based on GAITRite R© software are as follows: (1) Stride length
(in cm): anterior-posterior distance between the heel strikes of
two successive placements of the same foot; stride width (in
cm): lateral distance between the midlines of the right and left
heels; stride time (in ms): time elapsed from the first contact
of two consecutive footsteps of the same foot; swing time (in
ms): time elapsed from the last contact of the current footstep
to the first contact of the next footstep on the same foot; stance
time (in ms): time elapsed from the initial contact and the
last contact of consecutive footstep of the same foot; single
support time (in ms): time elapsed from the last contact of
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the opposite footfall to the initial contact of the next footstep
of the same foot; double support time (in ms): time elapsed
during which both feet are in ground contact; stride velocity
(in cm/s): stride length divided by the stride time; and walking
speed (in cm/s): distance walked divided by the ambulation
time.
Procedure for Clinical and Spatiotemporal Gait
Analysis Based on the Recorded Footfalls
All adults aged 65 and over should be systematically interviewed
or examined for gait disorders at least once per year. In addition,
those who report a fall or have an acute medical condition should
be asked about difficulties with gait and should be examined for
gait disorders.
Clinical assessment should be separated into two main parts:
global and analytic clinical assessment. The global assessment
detecting gait difficulties begins with watching individuals as
they walk into the examination room. The use of a walking
aid and its nature (i.e., cane, walker, personal assistance, and
supervision) should be noticed and the individual should be
asked about his/her subjective perception of gait difficulties.
This visual observation should be completed with one of the
two standardized motor tests to provide an objective measure
of gait performance: the TUG score and the gait speed
value. After this clinical assessment and if an abnormality is
recorded, a spatiotemporal gait analysis based on the recorded
footfalls (collection of all information described in Table 2)
in laboratory setting is suggested. If necessary and based on
abnormalities recorded during the clinical and clinical and
spatiotemporal gait analysis, an analysis outside the laboratory
using wearable sensors may be propose to obtain information
about gait during the individual’s everyday activities. The role
of other laboratory testing and diagnostic evaluation for gait
and balance disorders has not been well-studied, and there is no
recommended systematic investigation to perform. However, the
following complementary investigations are recommended: (1)
Bone radiography in the event of acute pain, joint deformation
and/or functional disability, (2) Standard 12-lead ECG in
case of dizziness, 3) Blood glucose level in patients with
diabetes, and (4) Serum 25OHD concentration if there is no
vitamin D supplementation. Cerebral imaging in the absence of
specific indications based on a clinical examination may not be
necessary.
Quantitative Reference Values for
Spatiotemporal Gait Parameters
Table 3 shows the group mean values, standard deviations and
CoV of spatiotemporal gait parameters separated by age groups
and sex. In most cases, men demonstrated greater performance
for mean values (i.e., less difference relative to normal values for
healthy young adults) than women, but not for CoV. This effect
was observed in the total sample as well as for the 65–74 year
age category. Interestingly, walking speed and stride velocity were
similar in both males and females when considering the total
sample and each age strata separately.
The results of multiple linear regression analyses exploring
the effects of age and sex on spatiotemporal gait parameters,
adjusted for BMI and test center are shown in Table 4. Increasing
age was associated with significant lower performance for mean
values and CoV for all gait parameters, except for the mean
value of stride width (P = 0.861) and CoV of double
support time (P = 0.186). Women demonstrated lower mean
values for all temporal gait parameters compared to men,
except for the mean value of double support time (P =
0.059) CoV of spatial parameters were significantly greater in
women compared to men. In addition, both mean and CoV of
stride velocity were significantly worst with increasing age in
women.
DISCUSSION
Standardized systematic assessment of three categories of
information, which included demographics, clinical features and
gait characteristics were selected for the development of gait
assessment guidelines. Two complementary sets of guidelines
have been proposed: a minimal data set and a full data set.
Concerning the quantitative reference values, we observed lower
values in several spatiotemporal gait parameters with age as well
as differences betweenmen and women. Age had a negative effect
on mean values and CoV, while sex was mainly associated with
mean values. Stride velocity parameters were affected both by age
and sex.
Our study provides quantitative normative values for
widely used and clinically relevant spatiotemporal gait
parameters. Compared to previous studies on this topic, the
strategy of recruiting participants through an intercontinental
initiative provides access to probably the highest number of
participants involved in a study exploring reference values
until now. Furthermore, we chose to select “very healthy”
older participants to avoid any interaction with morbidities
or cognitive impairments that can affect gait performance.
Previous studies have controlled for the potential effects of
morbidities using statistical analysis (Oberg et al., 1993; Oh-Park
et al., 2010; Bohannon and Williams Andrews, 2011; Hollman
et al., 2011; Hass et al., 2012). However, it has recently been
suggested that the strategy of statistical adjustment may be
limited and does not take into consideration the complex
interplay and potential effects of morbidities (Kressig et al., 2006;
Byrne and Pachana, 2011; Montero-Odasso et al., 2012). For
instance, a recent study reported the results of the independent
and combined effects of impairments of muscle strength,
distance vision, lower-limb proprioception, and cognition on
gait performance using pTUG and iTUG (Byrne and Pachana,
2011). It was shown that cognitive impairment, considered
either separately or in combination with any other subsystem
decline, notably muscle strength, was strongly associated
with decreased performance on the pTUG and delta TUG
scores. In contrast, lower-limb proprioceptive impairment
was associated with worse performance (i.e., lower) on the
iTUG. The subsystem’s impairment has been associated with
worse (i.e., greater) delta TUG scores; the highest impact being
reported when combining muscle strength and cognition. In
our study, all participants were free of morbidities, and thus
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TABLE 4 | Multiple linear regression showing the association of spatiotemporal gait parameters (dependent variables) with age and sex (independent variables) adjusted
for body mass index and test center among participants (n = 954).
Spatiotemporal gait parameters*
(Dependent variables)
Independent variables
Age Sex
β [95%CI] P-value β [95%CI] P-value
STRIDE TIME
Mean value (ms) 3.14 [1.55; 4.73] <0.001 −50.62 [−65.85; −35.38] <0.001
CoV (%) 0.04 [0.02; −0.05] <0.001 00.13 [−0.00; 0.25] 0.056
SWING TIME
Mean value (ms) −0.52 [−1.03; −0.00] 0.049 −21.69 [−26.62; 16.76] <0.001
CoV (%) 0.10 [0.07; 0.12] <0.001 −0.02 [0-0.25; 0.21] 0.880
STANCE TIME
Mean value (ms) 3.51 [2.34; 4.69] <0.001 −31.11 [−42.38; −19.83] <0.001
CoV (%) 0.03 [0.01; 0.05] 0.004 0.14 [−0.04; 0.31] 0.122
SINGLE SUPPORT TIME
Mean value (ms) −0.59 [−1.10; −0.09] 0.021 −22.66 [−27.50; −17.82] <0.001
CoV (%) 0.10 [0.08; 0.13] <0.001 −0.00 [−0.23; 0.22] 0.992
DOUBLE SUPPORT TIME
Mean value (ms) −4.03 [3.14; 4.92] <0.001 −8.22 [−16.73; 0.30] 0.059
CoV (%) −0.03 [−0.06; 0.01] 0.186 0.34 [−0.01; 0.70] 0.057
STRIDE LENGTH
Mean value (cm) −1.49 [−1.68; −1.29] <0.001 −14.48 [−16.34; 12.62] <0.001
CoV (%) 0.07 [0.06; 0.09] <0.001 0.22 [0.08; 0.36] 0.002
STRIDE WIDTH
Mean value (cm) 0.00 [−0.04; −0.04] 0.861 −0.95 [−1.33; −0.57] <0.001
CoV (%) 0.77 [0.11; 1.44] 0.023 8.09 [1.71; 14.47] 0.013
STRIDE VELOCITY
Mean value (cm/s) −1.47 [−1.75; −1.20] <0.001 −2.62 [−5.23; −0.01] 0.049
CoV (%) 0.05 [0.03; 0.07] <0.001 0.27 [0.08; 0.46] 0.005
ms, millisecond; s, second; cm, centimeter; CoV, coefficient of variation; CI, confidence interval; β, coefficient of regression corresponding to a decrease or increase in value of gait
parameters; *Used as dependent variable in the multiple linear regression. P-value significant (i.e., <0.05) indicated in bold; each linear Model is adjusted for Body mass index and test
center.
provided the opportunity to report real normative quantitative
reference values by age category from 65 to 85 years and
above. The decline in gait performance with age is consistent
with the literature and supports the validity of the reported
values.
Some limitations, however, need to be acknowledged. First,
the number of participants in the 85 and over age category was
low, probably because healthy individuals only represent a low
percentage of this age group. More effort needs to be made to
explore this population, as they currently represent the fastest
growing age group in many countries and have the highest
prevalence and incidence of gait disorders (American Geriatrics
Society and British Geriatrics Society and American Academy of
Orthopedic Surgeons Panel on Falls Prevention, 2001; Panel on
Prevention of Falls in Older Persons and American Geriatrics
Society and British Geriatrics Society, 2011). Second, because
this initiative merged data from clinical and research centers in
different countries and different clinical settings, assessment was
not strictly uniform even if the same procedures and equipment
were used.
CONCLUSIONS
The past decade has been characterized by an acceleration
of knowledge in medicine and science, particularly in the
area of neuroscience. Considerable efforts have been (and
continue to be) made in developing accessible and practical
technology-based assessment tools aiming at providing accurate
measurements of spatiotemporal gait parameters. These advances
challenge researchers and clinicians, pushing them to develop
new ways of thinking and working. Currently, new opportunities
exist as the result of working as part of an internationally
structured consortium. The GOOD initiative (Allali et al.,
2016) underscores the fact that there is still a lot of work
to do, but significant progress has been made and the
future is optimistic with respect to the development of
the Biomathics and Canadian Gait Consortiums. This work
represents an important first step in the development of
guidelines for clinical and spatiotemporal gait analysis based on
the recorded footfalls in laboratory setting and the definition
of quantitative reference values in healthy older adults. These
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guidelines facilitate the ability to work together and think
broadly and effectively in the field of gait disorders and
aging.
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